1. A dual center study to compare breath volatile organic compounds from smokers and non-smokers with and without COPD. (15th April 2016) Authors: Gaida, A; Holz, O; Nell, C; Schuchardt, S; Lavae-Mokhtari, B; Kruse, L; Boas, U; Langejuergen, J; Allers, M; Zimmermann, S; Vogelmeier, C; Koczulla, A R; Hohlfeld, J M Journal: Journal of breath research Issue: Volume 10:Number 2(2016:Jun.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P141 2-year follow-up of COPD patients in the non-interventional 'real-life' daccord study in germany. (15th November 2016) Authors: Worth, H; Buhl, R; Criée, CP; Kardos, P; Mailänder, C; Lossi, N; Vogelmeier, C Journal: Thorax Issue: Volume 71(2016)Supplement 3 Page Start: A159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P184 Applying the GOLD 2011 Classification to a Real-World COPD Population in Germany. (19th November 2012) Authors: Vogelmeier, C; Small, M; Broomfield, S; Vestbo, J Journal: Thorax Issue: Volume 67(2012)Supplement 2 Page Start: A144 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P194 Once-Daily QVA149 Provides Superior Bronchodilation and Improves Lung Function Versus Twice-Daily Fluticasone/Salmeterol in COPD Patients: The ILLUMINATE Study. (19th November 2012) Authors: Vogelmeier, C; Bateman, E; Pallante, J; Bryant, H; Alagappan, V; D'Andrea, P; He, E; Banerji, D Journal: Thorax Issue: Volume 67(2012)Supplement 2 Page Start: A149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P237 Comparison of COPD exacerbations with once-daily QVA149 versus twice-daily salmeterol/fluticasone combination: the ILLUMINATE study. (14th November 2013) Authors: Vogelmeier, C; Bateman, ED; Chen, H; Banerji, D Journal: Thorax Issue: Volume 68(2013)Supplement 3 Page Start: A184 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P285 The 'real-life' copd patient in the age of laba/lamas: an expansion of the daccord study. (15th November 2016) Authors: Vogelmeier, C; Worth, H; Buhl, R; Criée, CP; Mailaender, C; Lossi, N; Kardos, P Journal: Thorax Issue: Volume 71(2016)Supplement 3 Page Start: A243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P46 Frequency of COPD exacerbations in the German DACCORD Registry. (12th November 2015) Authors: Kardos, P; Buhl, R; Criée, C-P; Vogelmeier, C; Mailaender, C; Worth, H Journal: Thorax Issue: Volume 70(2015)Supplement 3 Page Start: A98 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. S35 Efficacy and safety of the direct switch from various previous treatments to glycopyrronium or indacaterol/glycopyrronium in patients with moderate copd: the crystal study. (15th November 2016) Authors: Vogelmeier, C; Aalamian-Mattheis, M; Greulich, T; Marin, J M; Castellani, W; Similowski, T; Ninane, V; Gaga, M; Lane, S; Nunez, X; Patalano, F; Clemens, A; Kostikas, K Journal: Thorax Issue: Volume 71(2016)Supplement 3 Page Start: A22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Suppression of pulmonary innate host defence in smokers. Issue 2 (13th October 2008) Authors: Herr, C; Beisswenger, C; Hess, C; Kandler, K; Suttorp, N; Welte, T; Schroeder, J-M; Vogelmeier, C; Group, R Bals for the CAPNETZ Study Journal: Thorax Issue: Volume 64:Issue 2(2009) Page Start: 144 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗